CCL5 and ovarian cancer: We found that neutralization of CCL5 significantly reduced NF-κB activity caused by CSLCs co-culture, in both A2780-derived (p<0.05, Fig. 7D) and human ovarian cancer tissue-derived NCSLCs (p<0.05, Fig. 7E).